Remove 2017 Remove Healthcare Remove Safety
article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. percent as EU average with some Member States as high as 25 percent).

article thumbnail

12 Brilliant Healthcare Marketing Campaign Initiatives

Medico Reach

After all, healthcare is a sensitive topic for most people, especially racial and ethnic minorities. This adds to the existing obstacles in the healthcare related marketing efforts. Healthcare advertisements that feature patient experiences can evoke powerful emotions. Operating a medical business can be difficult.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

The main objective was to evaluate the efficacy and safety of MBK-01 compared to fidaxomicin, providing significant insights into the potential of MBK-01 as a treatment for primary or recurrent CDI and contributing to the advancement of microbiome-based therapies. 2017; 55(7):1998-2008. McDonald CL, Gerding DN, Johnson S, et al.

Safety 111
article thumbnail

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

pharmaphorum

The UK healthcare sector is mourning one of the most eminent of its figures in the last few decades – Professor Sir Mike Rawlins – who has passed away at the age of 81. ” The post Tributes as former NICE, MHRA chair Sir Mike Rawlins dies appeared first on.

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO). To illustrate, let’s take the example of protectionist policies. References: 1.

article thumbnail

MHRA revamps UK clinical trial regulation with the promise of faster timelines

Pharmaceutical Technology

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stages. These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21.

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData. About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million.

Pharma 255